SDWIA
TOVX icon

Schwarz Dygos Wheeler Investment Advisors’s Theriva Biologics TOVX Stock Holding History

Schwarz Dygos Wheeler Investment Advisors’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75K Hold
15,000
– – ﹤0.01% 174
2026
Q1 		$2.94K Hold
15,000
– – ﹤0.01% 173
2025
Q4 		$3.16K Buy
+15,000
New +$4.44K ﹤0.01% 169

Other funds holding TOVX

GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Schwarz Dygos Wheeler Investment Advisors's TOVX Position: Q2 2026 in Review

Schwarz Dygos Wheeler Investment Advisors held its Theriva Biologics (TOVX) position steady in Q2 2026 at 15,000 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #174.

Schwarz Dygos Wheeler Investment Advisors first reported a position in TOVX in Q4 2025 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold TOVX as of Q2 2026.

  • Schwarz Dygos Wheeler Investment Advisors held 15,000 shares of Theriva Biologics worth $3.75K as of Q2 2026.
  • Schwarz Dygos Wheeler Investment Advisors left its Theriva Biologics share count unchanged in Q2 2026.
  • Theriva Biologics made up ﹤0.01% of Schwarz Dygos Wheeler Investment Advisors's portfolio in Q2 2026, its #174 holding.
  • Schwarz Dygos Wheeler Investment Advisors first reported a position in Theriva Biologics in Q4 2025 and has held it in 3 quarters since.
  • 6 funds tracked by Wall St. Rank held Theriva Biologics as of Q2 2026.

Based on Schwarz Dygos Wheeler Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.